Verona Pharma plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 6.32 M | $181.71 M | 159.52% | 7.75% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 5.58 M | $160.67 M | 0.00% | 6.85% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 5.01 M | $144.13 M | -34.37% | 6.15% |
| MAVERICK CAPITAL LTD | 11/14/2024 | 4.22 M | $121.29 M | 36.32% | 5.17% |
| VIVO CAPITAL, LLC | 11/13/2024 | 3.55 M | $102.13 M | 0.00% | 4.36% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 3.38 M | $97.36 M | 2.10% | 4.15% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 3.18 M | $91.49 M | -20.50% | 3.90% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 2.43 M | $69.79 M | 359.63% | 2.98% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 1.88 M | $54.05 M | 19.55% | 2.31% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 1.84 M | $52.80 M | -3.17% | 2.25% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 1.74 M | $50.09 M | 54.33% | 2.14% |
| CALIGAN PARTNERS LP | 11/14/2024 | 1.44 M | $41.34 M | -22.07% | 1.76% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.43 M | $41.25 M | 34.96% | 1.76% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.34 M | $38.41 M | 40.64% | 1.64% |
| BELLEVUE GROUP AG | 11/14/2024 | 1.22 M | $35.10 M | 7.57% | 1.50% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.18 M | $33.89 M | 1,048.00% | 1.45% |
| AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 1.12 M | $32.09 M | 0.00% | 1.37% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 1.11 M | $31.97 M | 100.00% | 1.36% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.04 M | $30.02 M | -4.51% | 1.28% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 985,076 | $28.34 M | 4.84% | 1.21% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 876,604 | $25.22 M | -0.16% | 1.08% |
| CANDRIAM S.C.A. | 11/13/2024 | 772,997 | $22.24 M | 0.00% | 0.95% |
| FMR LLC | 11/13/2024 | 716,588 | $20.62 M | -0.43% | 0.88% |
| DUQUESNE FAMILY OFFICE LLC | 11/14/2024 | 686,045 | $19.74 M | 100.00% | 0.84% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 650,000 | $18.70 M | -7.14% | 0.80% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 626,452 | $18.02 M | 5.22% | 0.77% |
| TRI LOCUM PARTNERS LP | 11/14/2024 | 593,980 | $17.09 M | 100.00% | 0.73% |
| MORGAN STANLEY | 11/14/2024 | 590,909 | $17.00 M | -31.61% | 0.73% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 572,928 | $16.48 M | 100.00% | 0.70% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 559,728 | $19.18 M | 100.00% | 0.69% |
| WOODLINE PARTNERS LP | 11/14/2024 | 507,945 | $14.61 M | 1.35% | 0.62% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 504,049 | $14.50 M | -17.51% | 0.62% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 434,738 | $12.51 M | 100.00% | 0.53% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 409,070 | $11.77 M | -52.18% | 0.50% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 405,741 | $11.67 M | -0.02% | 0.50% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 378,004 | $10.88 M | -1.61% | 0.46% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 358,447 | $10.31 M | 6.20% | 0.44% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 348,866 | $10.04 M | 14.52% | 0.43% |
| AXA S.A. | 11/14/2024 | 278,025 | $8.00 M | 100.00% | 0.34% |
| ROSALIND ADVISORS, INC. | 10/30/2024 | 275,000 | $7.91 M | 10.00% | 0.34% |
| CITADEL ADVISORS LLC | 11/14/2024 | 263,400 | $7.58 M | 65.76% | 0.32% |
| MOODY ALDRICH PARTNERS LLC | 10/22/2024 | 252,752 | $7.27 M | -14.59% | 0.31% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 250,000 | $7.19 M | 100.00% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 239,300 | $6.88 M | 888.84% | 0.29% |
| ALERCE INVESTMENT MANAGEMENT, L.P. | 11/13/2024 | 205,880 | $5.92 M | -3.34% | 0.25% |
| KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2024 | 200,000 | $5.75 M | 0.00% | 0.25% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 195,225 | $5.62 M | -43.82% | 0.24% |
| KNOTT DAVID M JR | 11/13/2024 | 180,000 | $5.18 M | -11.33% | 0.22% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 176,000 | $5.06 M | 44.74% | 0.22% |
| 1492 CAPITAL MANAGEMENT LLC | 11/13/2024 | 161,055 | $4.63 M | -1.58% | 0.20% |
Verona Pharma plcinstitutional Ownership - FAQ's
During the previous two years, 171 institutional investors and hedge funds held shares of Verona Pharma plc. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 6.32 M
NEA Management Company, LLC: 5.58 M
RA CAPITAL MANAGEMENT, L.P.: 5.01 M
MAVERICK CAPITAL LTD: 4.22 M
Vivo Capital, LLC: 3.55 M
Frazier Life Sciences Management, L.P.: 3.38 M
82.76% of Verona Pharma plc stock is owned by institutional investors.
Institutional investors have bought a total of 71.06 M shares in the last 24 months. This purchase volume represents approximately $3.20 B in transactions.